The Role of Diagnostic Imaging in Macular Telangiectasia Type 2

Overview

Journal Fed Pract

Specialty Health Services

Date 2022 Feb 18

PMID 35177889

Authors

Brett Zerbinopoulos

Elina Goman-Baskin

Paul B Greenberg

Richard Bryan

Claire Messina

Affiliations

Soon will be listed here.

Abstract

While uncommon with subtle findings, macular telangiectasia type 2 can be diagnosed with careful retinal examination and selective use of diagnostic imaging.

Citing Articles

High-Resolution Imaging in Macular Telangiectasia Type 2: Case Series and Literature Review.

Mirescu A, Balta F, Barac R, Deleanu D, Tofolean I, Balta G Diagnostics (Basel). 2024; 14(13).

PMID: 39001242 PMC: 11241511. DOI: 10.3390/diagnostics14131351.

References

GASS J, Oyakawa R . Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 1982; 100(5):769-80. DOI: 10.1001/archopht.1982.01030030773010. View

Heeren T, Kitka D, Florea D, Clemons T, Chew E, Bird A . LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2. Retina. 2017; 38 Suppl 1:S20-S26. PMC: 8326028. DOI: 10.1097/IAE.0000000000001715. View

Roisman L, Rosenfeld P . Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2. Dev Ophthalmol. 2016; 56:146-58. DOI: 10.1159/000442807. View

Khodabande A, Roohipoor R, Zamani J, Mirghorbani M, Zolfaghari H, Karami S . Management of Idiopathic Macular Telangiectasia Type 2. Ophthalmol Ther. 2019; 8(2):155-175. PMC: 6514016. DOI: 10.1007/s40123-019-0170-1. View

Tzaridis S, Heeren T, Mai C, Thiele S, Holz F, Charbel Issa P . Right-angled vessels in macular telangiectasia type 2. Br J Ophthalmol. 2019; 105(9):1289-1296. PMC: 8380913. DOI: 10.1136/bjophthalmol-2018-313364. View

Chew E, Clemons T, Jaffe G, Johnson C, Farsiu S, Lad E . Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial. Ophthalmology. 2018; 126(4):540-549. PMC: 8365464. DOI: 10.1016/j.ophtha.2018.09.041. View

Micevych P, Lee H, Fawzi A . Overlap between telangiectasia and photoreceptor loss increases with progression of macular telangiectasia type 2. PLoS One. 2019; 14(10):e0224393. PMC: 6816569. DOI: 10.1371/journal.pone.0224393. View

Christakis P, Fine H, Wiley H . The Diagnosis and Management of Macular Telangiectasia. Ophthalmic Surg Lasers Imaging Retina. 2019; 50(3):139-144. DOI: 10.3928/23258160-20190301-02. View

Charbel Issa P, Heeren T, Kupitz E, Holz F, Berendschot T . VERY EARLY DISEASE MANIFESTATIONS OF MACULAR TELANGIECTASIA TYPE 2. Retina. 2015; 36(3):524-34. DOI: 10.1097/IAE.0000000000000863. View

10.

Wu L . When is macular edema not macular edema? An update on macular telangiectasia type 2. Taiwan J Ophthalmol. 2017; 5(4):149-155. PMC: 5602132. DOI: 10.1016/j.tjo.2015.09.001. View

11.

Sauer L, Gensure R, Hammer M, Bernstein P . Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2. Ophthalmol Retina. 2018; 2(6):587-598. PMC: 6089530. DOI: 10.1016/j.oret.2017.10.008. View

12.

Heeren T, Clemons T, Scholl H, Bird A, Holz F, Charbel Issa P . Progression of Vision Loss in Macular Telangiectasia Type 2. Invest Ophthalmol Vis Sci. 2015; 56(6):3905-12. DOI: 10.1167/iovs.15-16915. View